TNF Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets

Intangible Assets

3 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Note 8 Intangible Assets

Intangible assets as of March 31, 2015 and December 31, 2014 and the movements for the three months then ended are as follows:

						Distributor &
		Patents &				Customer
		Trademarks				Relationships				Totals
*Cost or Deemed Cost*
At December 31, 2014		$	3,851,495			$	1,270,639			$	5,122,134
Additions			-				-				-
Disposals			-				-				-
At March 31, 2015		$	3,851,495			$	1,270,639			$	5,122,134

*Accumulated Amortization*
At December 31, 2014		$	1,675,430			$	1,270,639			$	2,946,069
Amortization Charge			64,643				-				64,643
Disposals			-				-				-
At March 31, 2015		$	1,740,073			$	1,270,639			$	3,010,712

*Net Book Value*
At December 31, 2014		$	2,176,065			$	-			$	2,176,065
At March 31, 2015		$	2,111,422			$	-			$	2,111,422

Amortization expense was $64,643 for the three months ended March 31, 2015 and 2014.